AMD Places Second Order for Axcelis' Single Wafer Optima Technology; Optima's Implant Precision and Angle Control Key Advantages in Forming AMD's Advanced Transistors.BEVERLY, Mass. -- Axcelis Technologies Axcelis Technologies, Inc. NASDAQ: ACLS engages in the design, manufacture, and servicing of capital equipment for the semiconductor manufacturing industry worldwide. , Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : ACLS ACLS abbr. advanced cardiac life support ) has received a follow-on order from AMD (Advanced Micro Devices, Inc., Sunnyvale, CA, www.amd.com) A major manufacturer of semiconductor devices including x86-compatible CPUs, embedded processors, flash memories, programmable logic devices and networking chips. for its single wafer Optima MD implanter. The system will ship in September to AMD's 300mm fab in Dresden, Germany, where it will enable production of advanced transistors using 65nm and 45nm device technologies. AMD was the first device maker to select Axcelis' single wafer implant technology last year. Since then, the Optima platform has gained rapid market acceptance, with orders from multiple customers around the globe. "The relationship between AMD and Axcelis continues to strengthen as we achieve major performance milestones with our initial tool placement," said Mary Puma, chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Axcelis. "In particular, the Optima MD provides unmatched precision in the areas of dopant dopant Any impurity added to a semiconductor to modify its electrical conductivity. The most common semiconductors, silicon and germanium, form crystalline lattices in which each atom shares electrons with four neighbours (see bonding). placement and angle control - two key advantages when producing advanced devices. Moreover, the platform's broad energy range delivers the flexibility and capital efficiency AMD needs to achieve its productivity goals." The Optima MD is the first tool in Axcelis' new series of simple, cost-effective implanters that give users complete, extendible applications coverage in and beyond the 65nm technology node. With a broad energy range of 500eV to 750keV, the system supports a wide array of low energy, mid-dose implant applications, especially HALO processes. The Optima MD also enables customers to cover evolving well and channel implants while still achieving high levels of productivity for more traditional implant applications. About AMD AMD (NYSE NYSE See: New York Stock Exchange :AMD) designs and produces innovative microprocessors, Flash memory devices and low-power processor solutions for the computer, communications and consumer electronics industries. AMD is dedicated to delivering standards-based, customer-focused solutions for technology users, ranging from enterprises and governments to individual consumers. For more information, visit www.amd.com. About Axcelis Technologies, Inc. Axcelis Technologies, Inc., headquartered in Beverly, Massachusetts, provides innovative, high-productivity solutions for the semiconductor industry. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation, rapid thermal processing Rapid Thermal Processing (or RTP) refers to a semiconductor manufacturing process which heats silicon wafers to high temperatures (up to 1200 C or greater) on a timescale of several seconds or less. , and cleaning and curing systems. Axcelis Technologies has key product development centers in Beverly, Massachusetts, as well as in Toyo, Japan through its joint venture, SEN. The company's Internet address is: www.axcelis.com. Forward-Looking Statements This press release includes certain statements, known as "forward-looking statements," which express the current expectations of Axcelis management. Product manufacturing and delivery issues, customer order push-outs or cancellations and product performance could cause actual results to differ materially from those currently anticipated as expressed in this press release. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. filed by Axcelis and in other filings from time to time with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion